BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/4/2020 9:56:59 AM | Browse: 741 | Download: 1262
 |
Received |
|
2020-08-28 18:31 |
|
Peer-Review Started |
|
2020-08-28 18:31 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-09-29 18:25 |
|
Revised |
|
2020-10-03 12:44 |
|
Second Decision |
|
2020-10-19 08:46 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-10-20 03:11 |
|
Articles in Press |
|
2020-10-20 03:11 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-11-02 00:33 |
|
Typeset the Manuscript |
|
2020-12-01 07:49 |
|
Publish the Manuscript Online |
|
2020-12-04 09:56 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Retrospective Study |
| Article Title |
Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hong-Ming Zhu, Yan Li, Bang-Yi Li, Shuang Yang, Ding Peng, Xiaojiao Yang, Xue-Lian Sun and Mei Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mei Zhang, MD, Chief Physician, Occupational Physician, Professor, Department of Gastroenterology, Xuanwu Hospital of Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing 100053, China. zhang2955@sina.com |
| Key Words |
COVID-19; Glucocorticoids; Methylprednisolone; Cytokine storm; Coronavirus infections; Cytokines |
| Core Tip |
Glucocorticoids were used in the treatment of severe acute respiratory syndrome, influenza A and coronavirus disease 2019 (COVID-19) in the past. Many studies believe that glucocorticoids can effectively reduce inflammation caused by viruses. In this manuscript, 102 patients with severe and critical COVID-19 were studied and divided into treatment group and control group according to methylprednisolone use. We found that the difference in mortality between both groups was insignificant (P = 0.655), and the results showed that methylprednisolone treatment did not improve prognosis. |
| Publish Date |
2020-12-04 09:56 |
| Citation |
Zhu HM, Li Y, Li BY, Yang S, Peng D, Yang X, Sun XL, Zhang M. Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases. World J Clin Cases 2020; 8(23): 5952-5961 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i23/5952.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i23.5952 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
